| |
| |
|
| Insider
Information: |
Lian Brian |
| Relationship: |
President & CEO, Direc... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
2,266,453 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$119,510,067 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,266,453 |
|
|
| Total
Value |
$119,510,067 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Viking Therapeutics, Inc. |
VKTX |
President & CEO, Direc... |
2024-03-27 |
2,266,453 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
48 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VKTX |
Viking Therapeutics, Inc. |
President & CEOOfficer |
• • – |
2015-04-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,650,000 |
|
- |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2020-01-19 |
4 |
D |
$7.18 |
$22,940 |
D/D |
(3,195) |
1,704,312 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2019-01-19 |
4 |
D |
$8.78 |
$38,044 |
D/D |
(4,333) |
1,560,152 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2021-01-19 |
4 |
D |
$6.68 |
$37,481 |
D/D |
(5,611) |
1,894,181 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2020-01-03 |
4 |
D |
$7.77 |
$52,696 |
D/D |
(6,782) |
1,707,507 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2018-05-04 |
4 |
D |
$4.22 |
$42,563 |
D/D |
(10,086) |
1,483,012 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2015-05-04 |
4 |
A |
$0.00 |
$0 |
D/D |
12,658 |
1,436,752 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2015-05-04 |
4 |
A |
$9.49 |
$155,124 |
D/D |
16,346 |
1,453,098 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2021-01-04 |
4 |
D |
$5.80 |
$98,443 |
D/D |
(16,973) |
1,899,792 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2020-09-15 |
4 |
D |
$6.25 |
$119,950 |
D/D |
(19,192) |
1,742,363 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2022-01-04 |
4 |
D |
$4.62 |
$122,116 |
D/D |
(26,432) |
2,036,686 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2021-09-28 |
4 |
D |
$6.50 |
$180,375 |
D/D |
(27,750) |
1,924,807 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2023-01-04 |
4 |
D |
$8.42 |
$240,972 |
D/D |
(28,619) |
2,272,963 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2021-01-03 |
4 |
D |
$5.63 |
$177,598 |
D/D |
(31,545) |
1,712,432 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2023-04-19 |
4 |
AS |
$21.45 |
$750,750 |
D/D |
(35,000) |
2,242,963 |
0 |
% |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2024-01-30 |
4 |
AS |
$23.95 |
$838,250 |
D/D |
(35,000) |
2,264,882 |
0 |
% |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2024-01-30 |
4 |
OE |
$1.23 |
$43,050 |
D/D |
35,000 |
2,299,882 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2022-01-03 |
4 |
D |
$4.88 |
$177,237 |
D/D |
(36,319) |
1,889,785 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2024-01-04 |
4 |
D |
$18.58 |
$734,876 |
D/D |
(39,552) |
2,264,882 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2018-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
1,493,098 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2023-05-01 |
4 |
AS |
$22.45 |
$1,010,250 |
D/D |
(45,000) |
2,197,963 |
0 |
% |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2024-02-09 |
4 |
AS |
$29.90 |
$1,345,500 |
D/D |
(45,000) |
2,139,882 |
0 |
% |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2023-04-13 |
4 |
OE |
$1.88 |
$102,152 |
D/D |
54,336 |
2,387,299 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2020-09-15 |
4 |
A |
$0.00 |
$0 |
D/D |
55,500 |
1,761,555 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2021-09-28 |
4 |
A |
$0.00 |
$0 |
D/D |
55,500 |
1,952,557 |
0 |
- |
|
48 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
